1. Home
  2. EFSI vs ORGO Comparison

EFSI vs ORGO Comparison

Compare EFSI & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eagle Financial Services Inc

EFSI

Eagle Financial Services Inc

HOLD

Current Price

$45.66

Market Cap

225.9M

Sector

Finance

ML Signal

HOLD

Logo Organogenesis Holdings Inc.

ORGO

Organogenesis Holdings Inc.

HOLD

Current Price

$1.57

Market Cap

239.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EFSI
ORGO
Founded
1881
1985
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
225.9M
239.3M
IPO Year
1996
2016

Fundamental Metrics

Financial Performance
Metric
EFSI
ORGO
Price
$45.66
$1.57
Analyst Decision
Buy
Strong Buy
Analyst Count
4
2
Target Price
$41.50
$8.50
AVG Volume (30 Days)
39.1K
663.1K
Earning Date
04-23-2026
05-07-2026
Dividend Yield
3.26%
N/A
EPS Growth
N/A
1600.00
EPS
1.61
N/A
Revenue
N/A
$564,169,000.00
Revenue This Year
$31.93
N/A
Revenue Next Year
$4.38
$26.27
P/E Ratio
$28.74
N/A
Revenue Growth
N/A
17.04
52 Week Low
$31.44
$1.54
52 Week High
$46.95
$7.08

Technical Indicators

Market Signals
Indicator
EFSI
ORGO
Relative Strength Index (RSI) 68.70 32.68
Support Level $38.81 $1.54
Resistance Level N/A $2.58
Average True Range (ATR) 1.38 0.09
MACD 0.35 0.01
Stochastic Oscillator 80.39 2.70

Price Performance

Historical Comparison
EFSI
ORGO

About EFSI Eagle Financial Services Inc

Eagle Financial Services Inc is a locally owned and managed financial institution. It offers retail and commercial banking services, including demand, savings and time deposits and consumer, mortgage, and commercial loans. It also offers telephone banking, internet banking, and mobile banking to its customers. The Company has three reportable operating segments, Community Banking, Marine Lending and Wealth Management. It generates a majority of its revenue from the Community Banking segment.

About ORGO Organogenesis Holdings Inc.

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.

Share on Social Networks: